Bessemer Group’s BioLife Solutions BLFS Stock Holding History

Bessemer Group’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2K	Hold	88	–	–	﹤0.01%	2384
2026 Q1	$2K	Sell	88 -50	-36%	-$1.1K	﹤0.01%	2350
2025 Q4	$3K	Buy	138 +39	+39%	+$1.02K	﹤0.01%	2321
2025 Q3	$2K	Buy	99 +49	+98%	+$1.16K	﹤0.01%	2298
2025 Q2	$1K	Hold	50	–	–	﹤0.01%	2278
2025 Q1	$1K	Hold	50	–	–	﹤0.01%	2315
2024 Q4	$1K	Hold	50	–	–	﹤0.01%	2311
2024 Q3	$1K	Buy	+50	New	+$1.18K	﹤0.01%	2348
2023 Q4	–	Sell	-190	Closed	-$3K	–	2153
2023 Q3	$3K	Sell	190 -807	-81%	-$12.7K	﹤0.01%	1841
2023 Q2	$22K	Buy	997 +52	+6%	+$1.09K	﹤0.01%	1511
2023 Q1	$21K	Hold	945	–	–	﹤0.01%	1370
2022 Q4	$17K	Sell	945 -380,274	-100%	-$7.85M	﹤0.01%	1336
2022 Q3	$8.67M	Buy	+381,219	New	+$8.16M	0.02%	264

Other funds holding BLFS

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bessemer Group's BLFS Position: Q2 2026 in Review

Bessemer Group held its BioLife Solutions (BLFS) position steady in Q2 2026 at 88 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #2384.

Bessemer Group first reported a position in BLFS in Q3 2022 and has held it in 13 quarters since. The position peaked at $8.67M in Q3 2022. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

Bessemer Group held 88 shares of BioLife Solutions worth $2K as of Q2 2026.
Bessemer Group left its BioLife Solutions share count unchanged in Q2 2026.
BioLife Solutions made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #2384 holding.
Bessemer Group first reported a position in BioLife Solutions in Q3 2022 and has held it in 13 quarters since.
Bessemer Group's BioLife Solutions position peaked at $8.67M in Q3 2022.
216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.